Nypro Healthcare, a US multinational involved in drug delivery, diagnostic and medical devices and manufactures inhalation and injectable devices, will increase its workforce from 360 to 460.
The company will expand its operation and open a new medical device development centre.
Mr Kenny said Ireland's reputation as a leading location for business and investment in the life-sciences sector was further boosted by the announcement.
"Maintaining Ireland as an attractive location for investment is a priority for Government and is recognised by long-established companies such as Nypro, who have had a presence here since 1980," he said.
Mr Bruton paid tribute to the company, pointing out how Nypro had changed its business from making products like printer cartridges to now supplying solely for the medical devices industry.